Cargando…
Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report
BACKGROUND: Fulminant cardiac involvement in COVID-19 patients has been reported; the underlying suspected mechanisms include myocarditis, arrhythmia, and cardiac tamponade. In parallel, atrial fibrillation is common in the elderly population which is at particularly high risk for COVID-19 morbidity...
Autores principales: | Schnaubelt, Sebastian, Breyer, Marie-Kathrin, Siller-Matula, Jolanta, Domanovits, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337643/ https://www.ncbi.nlm.nih.gov/pubmed/33089045 http://dx.doi.org/10.1093/ehjcr/ytaa166 |
Ejemplares similares
-
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF (PREvention oF Thromboembolic Events–European Registry in Atrial Fibrillation)
por: Patti, Giuseppe, et al.
Publicado: (2017) -
Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation
por: Niederdöckl, Jan, et al.
Publicado: (2019) -
The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis
por: Schnaubelt, Sebastian, et al.
Publicado: (2020) -
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis
por: Grajek, Stefan, et al.
Publicado: (2021) -
The personalized antithrombotic management of atrial fibrillation with intermediate thromboembolic risk: a case report
por: Hammer, Andreas, et al.
Publicado: (2020)